[go: up one dir, main page]

ES2174834T3 - Compuestos oligomericos aromaticos utiles como mimeticos de macromoleculas bioactivas. - Google Patents

Compuestos oligomericos aromaticos utiles como mimeticos de macromoleculas bioactivas.

Info

Publication number
ES2174834T3
ES2174834T3 ES92912715T ES92912715T ES2174834T3 ES 2174834 T3 ES2174834 T3 ES 2174834T3 ES 92912715 T ES92912715 T ES 92912715T ES 92912715 T ES92912715 T ES 92912715T ES 2174834 T3 ES2174834 T3 ES 2174834T3
Authority
ES
Spain
Prior art keywords
oligomeric compounds
compounds useful
mimetics
disorders
bioactive macromolecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92912715T
Other languages
English (en)
Inventor
John R Regan
Daniel G Mcgarry
Michael N Chang
Jeffrey N Barton
Jack Newman
Schmuel Ben-Sasson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Rorer International Holdings Inc
Original Assignee
Rhone Poulenc Rorer International Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer International Holdings Inc filed Critical Rhone Poulenc Rorer International Holdings Inc
Application granted granted Critical
Publication of ES2174834T3 publication Critical patent/ES2174834T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G8/00—Condensation polymers of aldehydes or ketones with phenols only
    • C08G8/04—Condensation polymers of aldehydes or ketones with phenols only of aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polyamides (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

ESTA INVENCION SE REFIERE A COMPUESTOS OLIGOMERICOS UTILES EN EL TRATAMIENTO DE TRASTORNOS CARDIOVASCULARES, METABOLICOS DE LOS HUESOS, HIPOLIPIDEMICOS, NEURONALES GASTROINTESTINALES Y DE LOS TEJIDOS CONJUNTIVOS MEDIANTE ELASTADAS Y TRASTORNOS QUE PUEDEN SER TRATADOS POR AGENTES EFICACES EN EL ENLACE DE ADN, O PROLIFERACION DE CELULAS DE MUSCULOS BLANDOS ANORMALES, A PROCESOS PARA LA PREPARACION DE TALES COMPUESTOS OLIGOMERICOS, A COMPOSICIONES FARMACEUTICOS QUE COMPRENDEN TALES COMPUESTOS OLIGOMERICOS, Y SU USO EN EL TRATAMIENTO DE TALES TRASTORNOS.
ES92912715T 1991-05-20 1992-05-20 Compuestos oligomericos aromaticos utiles como mimeticos de macromoleculas bioactivas. Expired - Lifetime ES2174834T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70306191A 1991-05-20 1991-05-20

Publications (1)

Publication Number Publication Date
ES2174834T3 true ES2174834T3 (es) 2002-11-16

Family

ID=24823810

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92912715T Expired - Lifetime ES2174834T3 (es) 1991-05-20 1992-05-20 Compuestos oligomericos aromaticos utiles como mimeticos de macromoleculas bioactivas.

Country Status (8)

Country Link
EP (1) EP0585371B1 (es)
AT (1) ATE216247T1 (es)
AU (1) AU2010792A (es)
DE (1) DE69232557T2 (es)
DK (1) DK0585371T3 (es)
ES (1) ES2174834T3 (es)
MX (1) MX9202389A (es)
WO (1) WO1992020350A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7238716B2 (en) 2000-12-28 2007-07-03 Takeda Pharmaceuticals Company Limited Alkanoic acid derivatives process for their production and use thereof
WO2002076959A1 (en) 2001-03-23 2002-10-03 Takeda Chemical Industries, Ltd. Five-membered heterocyclic alkanoic acid derivative
US7569577B2 (en) 2003-09-16 2009-08-04 Astrazeneca Ab Quinazoline derivatives as tyrosine kinase inhibitors
WO2007028051A2 (en) 2005-09-02 2007-03-08 Abbott Laboratories Novel imidazo based heterocycles
CN112135825A (zh) 2018-03-13 2020-12-25 夏尔人类遗传性治疗公司 血浆激肽释放酶抑制剂及其用途
ES2987744T3 (es) 2019-09-18 2024-11-18 Takeda Pharmaceuticals Co Inhibidores de calicreína plasmática y usos de los mismos
JP7695232B2 (ja) 2019-09-18 2025-06-18 武田薬品工業株式会社 ヘテロアリール血漿カリクレインインヒビター
MX2024010565A (es) 2022-03-02 2024-09-06 Horizon Therapeutics Ireland Dac Procedimiento de fabricacion de un antagonista cristalino del receptor edg-2.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2323481A (en) * 1939-03-14 1943-07-06 Du Pont Chemical process and composition
US2910484A (en) * 1957-05-09 1959-10-27 Ciba Pharm Prod Inc Polyhydric-aldehyde condensation products
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
IL95353A (en) * 1989-08-14 1995-01-24 Rhone Poulenc Rorer Int Pharmaceutical preparations containing aromatic polymers
EP0502117B1 (en) * 1989-11-22 1999-06-23 Rhone-Poulenc Rorer International (Holdings) Inc. Pharmaceutical compositions comprising polymers with alkyl- or heteroalkyl-aryl backbone
FR2672214A1 (fr) * 1991-01-31 1992-08-07 Rhone Poulenc Rorer Sa Application de polymeres biologiquement actifs, pour l'obtention d'un medicament pour le traitement d'infections a retrovirus.

Also Published As

Publication number Publication date
EP0585371A1 (en) 1994-03-09
DK0585371T3 (da) 2002-08-12
AU2010792A (en) 1992-12-30
MX9202389A (es) 1993-08-01
DE69232557T2 (de) 2002-10-24
WO1992020350A1 (en) 1992-11-26
ATE216247T1 (de) 2002-05-15
EP0585371A4 (en) 1994-07-13
DE69232557D1 (de) 2002-05-23
EP0585371B1 (en) 2002-04-17

Similar Documents

Publication Publication Date Title
IL225192A (en) Combinations of dextromethorphan and quinidine for the preparation of mental illness, neuropathic pain or brain injury
DE69434414D1 (de) Phosphatase oder ein entsprechendes derivat enthaltene pharmazeutische zusammensetzung
DK1133989T3 (da) Polymersammensætning til anvendelse i terapi
DE60216139D1 (de) Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
BRPI0416809A (pt) glicosamina
ATE457166T1 (de) Orale zusammensetzungen zur behandlung von diabetes
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
EP2497478A3 (en) Oligosaccaride compositions and use thereof in the treatment of infection
WO2003057144A3 (en) Change inhibitors of dipeptidyl peptidase iv
ATE316786T1 (de) Behandlung von mukositis
WO2004019884A3 (en) Agents and methods for enhancing bone formation
EP1158985A4 (en) GAMMA CARBOXYARYL SUBSTITUTED DIPHENYL HARVESE COMPOUNDS AS p38 KINASE HEMMER
WO2001068135A3 (en) Compositions and methods for affecting osteogenesis
DE19975006I2 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler St¦rungen.
ES2174834T3 (es) Compuestos oligomericos aromaticos utiles como mimeticos de macromoleculas bioactivas.
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
WO2000078800A3 (en) Combined decorin binding protein and outer surface protein compositions and methods of use
DE60004093D1 (de) Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten
WO2023183405A3 (en) Pharmaceutical compounds for the treatment of complement mediated disorders
RU98114982A (ru) Состав, содержащий диосгенин
BG105763A (en) Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
GR3020232T3 (en) LOW-MOLECULAR SULPHATED POLY--g(b)-2,6-FRUCTOFURANOSANES AND THEIR USE IN THE TREATMENT OF DEGENERATIVE ARTICULAR AILMENTS
WO2000030669A3 (en) Use of plasma phospholipid transfer proteins in treating cardiovascular dieases

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 585371

Country of ref document: ES